The Biden administration is expected to release the next batch of drugs that will be subject to Medicare price negotiations — ...

The round is one of Europe’s largest-ever biotech VC deals, signalling investor appetite for the booming weight loss market.

Naturally, more work is needed. Although GLS -1 agonists have been used in diabetes for 20 years, some of the newer findings ...

President-elect Donald Trump’s quest to buy Greenland from Denmark could make Ozempic and Wegovy, the weight-loss and diabetes drugs exploding in popularity, even more expensive for Americans.

President-elect Donald Trump’s threat to slap Denmark with tariffs to force its hand in giving up Greenland could lead to ...

GlobalData has named heart failure as the next disease to feel the sales-boosting power of GLP-1 drugs. The analysts expect ...

The best semaglutide dose for weight loss varies according to your starting weight, risks, and stage of treatment. Read to ...

New tests may show how much value a particular obese patient will get for a GLP-1 agonist prescription dollar.

In a recent episode of the global health and wellness show Bloom, host Gayle Guyardo welcomed Dr. Bharti Shetye, MD, MFOMA, a ...

Polls provide a useful window into understanding how Americans view their own weight and the recent availability of drugs ...

Popular diabetes drugs such as Ozempic and Trulicity are among 25 drugs Medicare has spent the most on but hasn't yet ...

Trump has pledged to implement "very high" tariffs on Denmark if it does not sell Greenland to the United States, also noting ...